340B – Understanding the Basics
About the Webinar:
As a board member, your responsibility is to assess the environment and look for both opportunities and threats that may impact the hospitals financial success. Have you assessed 340B lately? For many eligible hospitals, 340B is an answer to a long-standing problem of funding critical patient services that may be underfunded or poorly reimbursed. For others, 340B is seen as problematic and needs reform. Understanding the basics to the complex is key to hospitals successfully participating in the 340B program. Executives and their board members play a critical role in shaping the advocacy message, intent, and utilization of their organization’s 340B benefit. Learn how your role as a healthcare leader can help shape 340B into a sustainable benefit as industry dynamics shift. In this webinar series, we will discuss:
1. Define the intent, benefits, eligibility, and resources related to the 340B federal drug discount program.
2. Review the requirements, prohibitions, and integrity provisions for participation.
3. List the various models for accessing the drug discount, including contract pharmacy arrangements.
About the Speaker:
Lisa Scholz, Head of Industry Relations, joined Sentry after three years as Chief Operating Officer and Senior Vice President at 340B Health. She is a passionate and collaborative Health-System thought leader with a career path that spans Retail Pharmacy, Health-System Operations, Government, Association Management and Technology Solutions. Whether managing a 1000 bed health-system pharmacy operation or securing a government contract to provide assistance and expertise to Health Resources and Services Administration’s Office of Pharmacy Affairs (HRSA)- her in-depth understanding and experience in the market with complex organizations has assisted colleagues overcome and strengthen their policy, operations and technology in a changing environment.
As a trusted pharmacist, she represents Sentry at key industry events and hosts dialogue that engages with congressional contacts on legislative matters, National organizations on hot topics, and government agencies related to regulations to bridge health policy into leading practices with the support of technology. A native Texan, she has both a doctorate in pharmacy from the University of Houston and an MBA from Madison University. She is a registered pharmacist in Texas and graduate school preceptor.